Home Formulation Business Markets

South East Asia

Telmimarksans 80 & Citicoline Medicine Manufacturers

Marksans started operations in the Asian region in 2008. The vast and diverse Asian continent has been the focal point of Marksans international operations. With 300+ product registrations covering 9 countries, Marksans has a vantage position in the Asian region.

Backed by a strong product portfolio and a highly promising pipeline of pending product registrations, Marksans is well positioned to realize the true potential of these markets. Our aim is to reach out to different territories in the world’s largest continent by offering pharmaceutical products encompassing a wide range of therapeutic indications with impeccable quality at par with international standards.

  • Atormark
  • Rosuvamark
  • Telmimark
  • Clopimark
  • Simvamark
  • Omemark
  • Esomark
  • Lanzmark
  • Ferromark
  • Marklevo
  • Cefipimark
  • Imcilamark
  • Pizomark
  • Ceftazimark
  • Meromark
  • Oncology
  • Gastroenterology
  • Antidiabetic
  • Cardiovascular
  • Pain Management
  • Gynaecology
  • Cambodia
  • Myanmar
  • Philippines
  • Vietnam
  • Iraq
  • Sri Lanka
  • Kuwait
  • Afghanistan
  • Bangladesh